Group B:Concurrent chemoradiotherapy

3 trials

Sponsors

The Affiliated Cancer Hospital of Guizhou Medical University, Drum Tower Hospital, Cancer Center, Sun Yat-Sen University

Conditions

Cervical cancergastric/gastroesophageal junction adenocarcinomalocal regionally advanced nasopharyngeal carcinoma

Phase 2

Prospective randomized trial comparing concurrent chemoradiotherapy plus CIK cell therapy to concurrent chemoradiotherapy in patients with local regionally advanced nasopharyngeal carcinoma

Active, not recruitingChiCTR-TRC-08000262

Cancer Center, Sun Yat-Sen Universitylocal regionally advanced nasopharyngeal carcinoma

Start: 2008-01-01Updated: 2021-11-22

The efficacy and safety of Tislelizumab combined with Ociperlimab and chemotherapy in the perioperative treatment of resectable esophageal squamous cell carcinoma: a single arm phase II study

RecruitingChiCTR2400092029

Drum Tower Hospitalgastric/gastroesophageal junction adenocarcinoma

Start: 2023-03-15Updated: 2024-11-11

Phase 4

Comparative study on the efficacy and safety of CalliSpheres drug-loaded microsphere embolization and concurrent chemoradiotherapy in the treatment of advanced cervical cancer

RecruitingChiCTR2100050964

The Affiliated Cancer Hospital of Guizhou Medical UniversityCervical cancer

Start: 2021-09-01Updated: 2022-05-16

Related Papers

Concurrent chemoradiotherapy plus cytokine-induced killer cells therapy or observation in patients with locoregionally advanced nasopharyngeal carcinoma: A ten-year follow-up of a randomized, phase II study.

Journal of Clinical Oncology2026-05-27